Medicare Enrolled
Dr. Perry Herson, MD
Optician · Williston Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Herson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Herson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Herson
Dr. Perry Herson is an optician specialist in Williston Park, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Herson performed 4,153 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Herson received a total of $443,469 from 56 pharmaceutical and/or device companies across 1599 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Herson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 19% volume in NY
$443,469 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,153
Medicare services
Top 19% in NY for optician
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,298 | $109 | $260 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
935 | $103 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
510 | $8 | $10 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
451 | $10 | $40 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
297 | $139 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
186 | $79 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
142 | $139 | $385 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
136 | $138 | $375 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
115 | $31 | $90 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
40 | $124 | $315 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
29 | $80 | $210 |
| Fine needle aspiration biopsy, first growth A procedure using a thin needle to remove cells or fluid from a growth for examination. |
14 | $98 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$443,469
Total received (2018-2024)
Avg $63,353/year across 7 years
Top 1% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
1,599
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22,168
2023
$90,719
2022
$81,623
2021
$36,637
2020
$34,818
2019
$71,495
2018
$106,008
Payments by company (2024)
Mannkind Corporation
$12,883
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,445
Lilly USA, LLC
$2,543
Xeris Pharmaceuticals, Inc.
$437
Novo Nordisk Inc
$304
SANOFI-AVENTIS U.S. LLC
$253
Abbott Laboratories
$235
Amneal Pharmaceuticals LLC
$173
Esperion Therapeutics, Inc.
$168
Amgen Inc.
$144
IBSA Pharma Inc.
$120
Intra-Sana Laboratories
$104
VIVUS LLC
$71
ABBVIE INC.
$63
Corcept Therapeutics
$63
Dexcom, Inc.
$59
PFIZER INC.
$48
Tolmar, Inc.
$26
Ascendis Pharma Inc
$15
Antares Pharma, Inc.
$15
Top 3 companies account for 89.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$77,178
Boehringer Ingelheim Pharmaceuticals, Inc.
$76,597
SANOFI-AVENTIS U.S. LLC
$68,685
Intuity Medical Inc
$61,204
Lilly USA, LLC
$41,146
MannKind Corporation
$39,588
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34,134
Merck Sharp & Dohme Corporation
$18,096
Mannkind Corporation
$13,828
Novo Nordisk Inc
$1,623
Abbott Laboratories
$1,616
Insulet Corporation
$1,458
Amgen Inc.
$1,047
Xeris Pharmaceuticals, Inc.
$713
Corcept Therapeutics
$657
Amneal Pharmaceuticals LLC
$523
IBSA Pharma Inc.
$490
Dexcom, Inc.
$449
Medtronic MiniMed, Inc.
$417
ABBVIE INC.
$336
DEXCOM, INC.
$259
AbbVie Inc.
$248
AbbVie, Inc.
$217
Ipsen Biopharmaceuticals, Inc
$213
Becton, Dickinson and Company
$213
Shire North American Group Inc
$188
VIVUS LLC
$182
Amryt Pharma Holdings Ltd
$181
Ascensia Diabetes Care Us Inc.
$172
Esperion Therapeutics, Inc.
$168
GRT US Holding, Inc.
$151
Ascendis Pharma Inc
$140
GENZYME CORPORATION
$133
Tandem Diabetes Care, Inc.
$111
Intra-Sana Laboratories
$104
Medtronic, Inc.
$101
Acerus Pharmaceuticals Corporation
$96
Janssen Pharmaceuticals, Inc
$89
Horizon Therapeutics plc
$83
LifeScan, Inc.
$82
PFIZER INC.
$69
Zealand Pharma US, Inc.
$66
Aytu Bioscience, Inc
$60
Embecta Corp.
$55
Antares Pharma, Inc.
$40
VIVUS, Inc.
$39
Radius Health, Inc.
$37
RECORDATI_RARE_DISEASES_INC.
$37
Tolmar, Inc.
$26
Eisai Inc.
$20
Bigfoot Biomedical Inc
$19
Merck Sharp & Dohme LLC
$17
CeQur Corporation
$17
Senseonics, Incorporated
$17
Ferring Pharmaceuticals Inc.
$17
VistaPharm, Inc.
$14
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD ULTRA-FINE · BD Ultra-Fine · BYDUREON · Belviq · CEREZYME · CYCLOSET · CeQur Simplicity · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Korlym · LANTUS · LICART · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PAXLOVID · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · Qutenza · RECORLEV · RELTONE 200 MG · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Victoza · Wegovy · XIFAXAN · XIGDUO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
16,275
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Herson is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Herson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Herson performed 1,298 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Herson receive payments from pharmaceutical companies?
Yes. Dr. Herson received a total of $443,469 from 56 companies across 1,599 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Herson's costs compare to other opticians in Williston Park?
Dr. Herson's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Herson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Williston Park
Browse opticians in Williston Park ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology